Drug Patents owned by Plx Pharma

1. List of Vazalore drug patents

VAZALORE Litigations
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9101637 PLX PHARMA Methods of treating inflammation with compositions comprising lecithin oils and NSAIDS for protecting the gastrointestinal tract and providing enhanced therapeutic activity
Mar, 2022

(1 year, 2 months ago)

US8865187 PLX PHARMA Compositions comprising lecithin oils and NSAIDs for protecting the gastrointestinal tract and providing enhanced therapeutic activity
Mar, 2022

(1 year, 2 months ago)

US10786444 PLX PHARMA PH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same
Sep, 2032

(9 years from now)

US10646431 PLX PHARMA PH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same
Sep, 2032

(9 years from now)

US9226892 PLX PHARMA pH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same
Sep, 2032

(9 years from now)

US9216150 PLX PHARMA pH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same
Sep, 2032

(9 years from now)

Do you want to check out VAZALORE patents from before 2022?

Drugs and Companies using ASPIRIN ingredient

Market Authorisation Date: 14 January, 2013

Treatment: Treatment/prevention of cardiovascular disease; Temporary reduction of fever; Temporary relief of minor aches and pains; A method of targeting release of a non-steroidal anti-inflammatory drug (nsaid)...

Dosage: CAPSULE;ORAL

More Information on Dosage

VAZALORE family patents

19

United States

5

Japan

4

Korea, Republic of

3

China

3

Mexico

2

Hong Kong

2

Canada

2

Australia

2

European Union

1

Germany

1

Spain

1

Austria

1

Cyprus

1

Brazil

1

Portugal

1

Israel

1

Denmark

1

Slovenia

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in